Friday, April 30, 2010
IU Emerging Technologies Center
351 W. 10th Street
The Indiana Health Industry Forum welcomes a large delegation of biotechnology companies from Australian and New Zealand to Indiana on Friday, April 30. Please join us for a series of presentations by the Australian companies as they outline their interests for partnership, investment, alliances, licensing, and other joint venture opportunities with U.S. companies.
Dr. Anna Lavelle, CEO, (Mission Leader), AusBiotech
The participating Australian businesses are:
AusBiotech Ltd., Dr. Anna Lavelle, CEO, (Mission Leader) & Glenn Cross, COO – AusBiotech is Australia’s biotechnology industry organisation, which represents over 3,000 members, covering the human health, agricultural, medical device, bioinformatics, environmental and industrial sectors in biotechnology.
Bionomics Ltd., Dr. Deborah Rathjen, CEO, and Chair, AusBiotech Ltd. (Mission Leader) – Bionomics is a productive drug discovery and development engine room focused on new treatments for cancer and serious disorders of the central nervous system (CNS). Through application of its proprietary technology platforms, MultiCore®, Angene® and ionX®, Bionomics has generated multiple drug candidates and targets in the therapeutic areas of Cancer, Anxiety, Multiple Sclerosis and Epilepsy. The company has a strong out-license record in conjunction with its in-house development program which has seen two highly promising drugs enter clinical trials in the past two years.
NZBio Ltd., Bronwyn Dilley, CEO, NZBIO is the national peak body representing the bioscience based industries of New Zealand. In 2008, a deliberate move towards the emerging international dialogue on referring to a bioeconomy was adopted, with NZBIO now operating under the tagline “Creating a Sustainable Bioeconomy in New Zealand”.
Tyrian Diagnostics Pty. Ltd. Jenny Harry, CEO, & John O’Connor, Advisor, formerly Proteome Systems, Tyrian Diagnostics is a leading Australian company that generates new diagnostic and drug products using its internationally recognised proteomics expertise and technology. Tyrian Diagnostics is based in Sydney, Australia and has facilities in Boston, USA and Osaka, Japan. It employs approximately 100 people globally. Tyrian Diagnostics specialises in: Respiratory Disease and Neurodegenerative Disease and Aging
QRX Pharmaceuticals – Janette Dixon, Vice President, Global Development, QRxPharma Ltd. (ASX: QRX) is a clinical-stage specialty pharmaceutical company focused on the development and commercialisation of new treatments for pain management and central nervous system (CNS) disorders.
Living Cell Technologies – Susanne Clay, Chief Business Officer, LCT is a New Zealand based biotechnology company focused on developing living cell products for the treatment of diabetes, neurological disease and hemophilia.
New Business Horizons – Leslie Pryce, CEO, Leslie Pryce is an experienced pharmaceutical industry consultant who provides AMP&A. He has over twenty years of experience in corporate development working with international companies in the Asia Pacific region. His experience includes serving as Executive Vice President of Glaxo Korea where between 1983 and 1988 he established, and from 1986 headed up, Glaxo’s joint venture in that market building the foundations for what has become one of the largest pharmaceutical enterprises in that country. He previously held numerous positions for Colgate Palmolive where he served as Director of New Products and Business Development Far East. In 1992 Leslie, assisted by his wife Asae who is Japanese, established an independent consulting firm, New Business Horizons, and since then they have provided consulting services leading to the completion of a number of significant licensing deals with major firms in the Asia Pacific region.
Indiana Economic Development Corporation – Stephen Pattillo, Director, Australia & New Zealand, the IEDC office in Australia actively markets Indiana as a destination for the U.S. operations and investments of companies in Australia & New Zealand. IEDC Australia/New Zealand works closely with AusBiotech Ltd. and NZBio Ltd. to promote the life sciences sector in Indiana to biotech and medical device and diagnostic companies in Australia & New Zealand.
A networking lunch will be provided following the presentations. One-on-one meetings with the participants may also be arranged for the afternoon.
11:15 am – 12:30 pm – Australian Partnership Presentations
12:30 pm – 2:00 pm – Luncheon
2:15 pm – 5:30 pm – One-On-One meetings (once registered, you will be contacted to set up details)
Please RSVP/Register (http://www.ihif.org/conference/register/31):
1) company presentations
3) one-on-one meetings